权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

NCTN Deep South Research Consortium

NCTN 深南研究联盟

基本信息

批准号：
10159225
负责人：
MARY-ANN BJORNSTI
金额：
$ 53.27万
依托单位：
UNIVERSITY OF ALABAMA AT BIRMINGHAM
依托单位国家：
美国
项目类别：
财政年份：
2019
资助国家：
美国
起止时间：
2019-03-06 至 2025-02-28
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10159225
关键词：
Achievement Address Alabama American College of Radiology Imaging Network Area Arkansas Basic Science Cancer Biology Cancer Control Cancer Patient Cancer and Leukemia Group B Clinical Cancer Center Clinical Investigator Clinical Research Clinical Trials Clinical Trials Cooperative Group Clinical Trials Network Communities Community Outreach Comprehensive Cancer Center Cooperative Group Program Country Deep South Detection Diagnosis Doctor of Medicine Doctor of Philosophy Eastern Cooperative Oncology Group Enrollment Ensure Faculty Fostering Funding Gynecologic Oncology Group Home Hospitals Infrastructure Intention International Intervention Investigational Therapies Knowledge Lead Leadership Louisiana Malignant Neoplasms Mentors Minority Minority Participation Mississippi Names National Clinical Trials Network National Surgical Adjuvant Breast and Bowel Project Outcome Patients Phase Physicians Process Quality of life Radiation Therapy Oncology Group Recording of previous events Research Research Personnel Research Training Role Scientist Site Socioeconomic Status Southwest Oncology Group Training Training Programs Training and Infrastructure Translating Translational Research United States Universities Vision Work anticancer research cancer care cancer clinical trial cancer health disparity cancer prevention cancer risk clinical trial participant demographics ethnic minority population health disparity interest member minority health minority scientist next generation organizational structure patient population population based programs racial health disparity recruit survivorship translational scientist treatment trial

项目摘要

The University of Alabama at Birmingham Comprehensive Cancer Center (UAB CCC) has a long history of participation within the nation's cancer related Clinical Trials Cooperative Group Program. Specifically, UAB was a founding member of the GOG, and has been a member of RTOG, ECOG, ACRIN. CALGB, NSABP, and SWOG. UAB CCC is a current member of the ALLIANCE, ECOG-ACRIN, NRG and SWOG cooperative groups. The UAB NCTN Deep South Research Consortium (DSRC) is currently a Lead Academic Participating Site in the NCI's National Clinical Trials Network (NCTN) Program, and now submits this proposal to continue to serve the NCI in this capacity. It is our intention to continue as a leading contributor of scientific leaders and clinical trial participants to the NCTN Program in the U.S. and particularly in the Southeast. To accomplish this overall vision, we propose the following specific aims: 1) To further enhance the involvement of existing UAB CCC scientific leadership in NCTN Cooperative Group related clinical and translational research and to develop the next generation of NCTN Cooperative group scientific leaders within the UAB CCC, and 2) To further refine a clinical trials process within the DSRC that optimizes accrual of potentially eligible cancer patients and patients at risk for cancer to NCTN Cooperative Group clinical trials, and 3) To further increase minority accrual to NCTN Cooperative Group trials. We include in this proposal a detailed description of our DSRC cooperative group scientific and patient accrual contributions and accomplishments, a leadership and organizational structure for our Consortium, and how we intend to utilize existing DSRC infrastructure to achieve our aims. Further, we also include a detailed description of our Junior Investigator Recruitment and Mentoring Program.

阿拉巴马大学伯明翰综合癌症中心（UAB CCC）有着悠久的历史